HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 289/2/E301    most recent 00404.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Jethwa, P. H. Articles by Bloom, S. R. Search for Related Content PubMed PubMed Citation Articles by Jethwa, P. H. Articles by Bloom, S. R.

Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin

Department of Metabolic Medicine, Imperial College London, Hammersmith Campus, London, United Kingdom

Submitted 27 August 2004 ; accepted in final form 21 March 2005

Intracerebroventricular (ICV) administration of Neuromedin U (NMU), a hypothalamic neuropeptide, or leptin, an adipostat hormone released from adipose tissue, reduces food intake and increases energy expenditure. Leptin stimulates the release of NMU in vitro, and NMU expression is reduced in models of low or absent leptin. We investigated the role of NMU in mediating leptin-induced satiety. ICV administration of anti-NMU immunoglobulin G (IgG) (5 nmol) to satiated rats significantly increased food intake 4 h after injection, an effect seen for 8 h after injection. ICV administration of NMU (1 nmol) to fasted rats reduced food intake 1 h after injection compared with control, an effect attenuated by pretreatment with anti-NMU IgG. ICV administration of leptin (0.625 nmol) reduced 24-h food intake. This was partially attenuated by the administration of anti-NMU IgG [24 h after onset of dark phase: vehicle, 22.5 ± 2.0 g; leptin, 13.7 ± 2.3 g (P < 0.005 vs. vehicle), leptin/NMU IgG, 19.4 ± 1.3 g (P < 0.05 vs. leptin)]. Intraperitoneal administration of leptin (1.1 mg/kg body wt) reduced 24-h food intake. This was partially attenuated by ICV administration of anti-NMU IgG [24 h after onset of dark phase: vehicle, 31.4 ± 4.9 g; leptin, 20.8 ± 2.6 g (P < 0.01 vs. vehicle); leptin/NMU IgG, 28.7 ± 1.1 g (P < 0.01 vs. leptin)]. These results suggest that NMU plays a physiological role in the regulation of appetite and partially mediates the leptin-induced satiety.

intracerebroventricular; immunoblockade; anti-neuromedin U immunoglobulin G; antibody

This article has been cited by other articles:

				E. Egecioglu, K. Ploj, X. Xu, M. Bjursell, N. Salome, N. Andersson, C. Ohlsson, M. Taube, C. Hansson, M. Bohlooly-Y, et al. Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in mice Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E708 - E716. [Abstract] [Full Text] [PDF]

				P. J. Brighton, A. Wise, N. B. Dass, and G. B. Willars Paradoxical Behavior of Neuromedin U in Isolated Smooth Muscle Cells and Intact Tissue J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 154 - 164. [Abstract] [Full Text] [PDF]

				E. Vigo, J. Roa, R. Pineda, J. M. Castellano, V. M. Navarro, E. Aguilar, L. Pinilla, and M. Tena-Sempere Novel role of the anorexigenic peptide neuromedin U in the control of LH secretion and its regulation by gonadal hormones and photoperiod Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1265 - E1273. [Abstract] [Full Text] [PDF]

				H. Zeng, A. Gragerov, J. G. Hohmann, M. N. Pavlova, B. A. Schimpf, H. Xu, L.-J. Wu, H. Toyoda, M.-G. Zhao, A. D. Rohde, et al. Neuromedin U Receptor 2-Deficient Mice Display Differential Responses in Sensory Perception, Stress, and Feeding Mol. Cell. Biol., December 15, 2006; 26(24): 9352 - 9363. [Abstract] [Full Text] [PDF]